Concepedia

Saravanan Parthasarathy

SP

12

Publications

531

Citations

11

H-Index

2002

Active since

Affiliations

B.S. Abdur Rahman Crescent Institute of Science & Technology(Current)

Eli Lilly (United States)

Saravanan Parthasarathy is an author at B.S. Abdur Rahman Crescent Institute of Science & Technology specializing in engineering, predictive analytics, and data science.

ORCID

Top concepts

Publications per year

2002–2024

12

Publications

12

Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, in Human Cancer Cells

Bo Tan, Debra A. Young, Zhao-Hai Lu et al. · Journal of Biological Chemistry · 2012 · 173 citations · Full text

, , +19

Prediction of Cardiac Disease using Supervised Machine Learning Algorithms

R. Jane Preetha Princy, Saravanan Parthasarathy, P. Subha Hency Jose et al. · 2020 · 103 citations

, , +23

Discovery and characterization of LY2784544, a small-molecule tyrosine kinase inhibitor of JAK2V617F

Liandong Ma, Joshua R. Clayton, Richard A. Walgren et al. · Blood Cancer Journal · 2013 · 64 citations · Full text

The Power of Visual Imagery in Drug Design. Isopavines as a New Class of Morphinomimetics and Their Human Opioid Receptor Binding Activity

Stephen Hanessian, Saravanan Parthasarathy, Marc Mauduit et al. · Journal of Medicinal Chemistry · 2002 · 47 citations · Full text

Design, synthesis and structure–activity-relationship of 1,5-tetrahydronaphthyridines as CETP inhibitors

Maria-Carmen Fernandez, Ana Escribano, Ana Mateo et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 28 citations · Full text

, , +2

Rows per page

1–5 of 12